E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with J
>
Issuers starting with J, EM only
>
All stories on Jubilant Life Sciences Ltd.
>
Stories on Jubilant Life Sciences Ltd., EM only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Jubilant Life Sciences Ltd.
2/1/2021
EMLM
Jubilant Pharma early redeems $100 million of 4 7/8% notes due 2021
12/30/2019
EMLM
India’s Jubilant Life to redeem Rs. 7.45 billion nonconvertible debt
10/21/2019
EMLM
India’s Jubilant Life unit to redeem $100 million of 4 7/8% notes
11/1/2018
EM
S&P revises Jubilant Pharma view to positive
6/27/2018
EM
India’s Jubilant to issue Rs. 3.5 billion of redeemable debentures
6/22/2018
EM
India’s Jubilant to consider Rs. 7.5 billion non-convertible debentures
1/27/2017
EM
New Issue: India’s Jubilant places Rs. 4.95 billion 8.65% 2- to 5-year debentures
1/25/2017
EM
India’s Jubilant proposes Rs. 4.95 billion non-convertible debentures
10/24/2016
EM
India’s Jubilant Life board to discuss Rs. 10 billion of debentures
9/30/2016
EM
New Issue: India’s Jubilant Pharma prices $300 million 4 7/8% five-year bonds
10/29/2015
EM
India’s Jubilant Life approves up to $200 million in securities
5/7/2013
EM
India's Jubilant Life board mulls options for raising $250 million
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
